Anti-inflammatory therapy in Alzheimer's disease: Is hope still alive?

Journal of Neurology

Volumn 250, Issue 7, 2003, Pages 788-792

  Van Gool, Willem A ^b   Aisen, P S ^a   Eikelenboom, P ^b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Alzheimer's disease; Anti inflammatory drugs; Inflammation; Microglia; Therapy

Indexed keywords

ANTIINFLAMMATORY AGENT; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; DICLOFENAC; HYDROXYCHLOROQUINE; INDOMETACIN; MISOPROSTOL; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISONE;

ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; GASTROINTESTINAL SYMPTOM; HUMAN; INFLAMMATION; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW;

ALZHEIMER DISEASE; ANIMALS; ANTI-INFLAMMATORY AGENTS; CLINICAL TRIALS; HUMANS;

EID: 0042347804     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00415-003-1146-5     Document Type: Review

References (34)

1. Akiyama H, Barger S, Barnum S, et al. (2002) Inflammation and Alzheimer's disease. Neurobiol Aging 21:383-421
2. Eikelenboom P, Zhan SS, van Gool WA, Allsop D (1994) Inflammatory mechanisms in Alzheimer's disease. Trends Pharmacol Sci 15:447-450
3. Aisen PS, Davis KL (1994) Inflammatory mechanisms in Alzheimer's disease: implications for therapy. Am J Psychiatry 15:1105-1113
4. McGeer PL, McGeer EG (1995) The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases. Brain Res Brain Res Rev 21:195-218
5. Lue LF, Rydel R, Brigham EF, et al. (2001) Inflammatory repertoire of Alzheimer's disease and nondemented elderly microglia in vitro. Glia 35:72-79
6. Rogers J, Cooper NR, Webster S, et al. (1992) Complement activation by beta-amyloid in Alzheimer disease. Proc Natl Acad Sci U S A 89:10016-10020
7. McGeer PL, Schulzer M, McGeer EG (1996) Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies. Neurology 47:425-432
8. Aisen PS, Davis KL, Berg JD, et al. (2000) A randomized controlled trial of prednisone in Alzheimer's disease. Alzheimer's Disease Cooperative Study. Neurology 54:588-593
9. Rogers J, Kirby LC, Hempelman SR, et al. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43:1609-1611
10. Sainetti SM, Ingram DM, Talwalker S, Geis GS (2000) Results of a doubleblind, randomized, placebo-controlled study of celecoxib in the treatment of progression of Alzheimer's disease. Sixth International Stockholm/Springfield Symposium on Advances in Alzheimer Therapy: 180 (abstract)
11. Scharf S, Mander A, Ugoni A, Vajda F, Christophidis N (1999) A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology 53:197-201
12. van Gool WA, Weinstein HC, Scheltens PK, Walstra GJ (2001) Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet 358:455-460
13. Eikelenboom P, Rozemuller JM, Kraal G, et al. (1991) Cerebral amyloid plaques in Alzheimer's disease but not in scrapie-affected mice are closely associated with a local inflammatory process. Virchows Arch B Cell Pathol Incl Mol Pathol 60:329-336
14. Eikelenboom P, Veerhuis R (1996) The role of complement and activated microglia in the pathogenesis of Alzheimer's disease. Neurobiol Aging 17:673-680
15. Dickson DW, Lee SC, Mattiace LA, Yen SH, Brosnan C (1993) Microglia and cytokines in neurological disease, with special reference to AIDS and Alzheimer's disease. Glia 7:75-83
16. Griffin WS, Stanley LC, Ling C, et al. (1989) Brain interleukin 1 and S-100 immunoreactivity are elevated in Down syndrome and Alzheimer disease. Proc Natl Acad Sci U S A 86:7611-7615
17. Mrak RE, Griffinbc WS (2001) The role of activated astrocytes and of the neurotrophic cytokine S100B in the pathogenesis of Alzheimer's disease. Neurobiol Aging 22:915-922
18. Grimaldi LM, Casadei VM, Ferri C, et al. (2000) Association of early-onset Alzheimer's disease with an interleukin-1alpha gene polymorphism. Ann Neurol 47:361-365
19. Nicoll JA, Mrak RE, Graham DI, et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann Neurol 47:365-368
20. Morgan D, Diamond DM, Gottschall PE, et al. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408:982-985
21. Schenk D, Barbour R, Dunn W, et al. (1999) Immunization with amyloidbeta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400:173-177
22. Hoozemans JJ, Rozemuller AJ, Janssen I, de Groot CJ, Veerhuis R, Eikelenboom P (2001) Cyclooxygenase expression in microglia and neurons in Alzheimer's disease and control brain. Acta Neuropathol (Berl) 101:2-8
23. Ho L, Purohit D, Haroutunian V, et al. (2001) Neuronal cyclooxygenase 2 expression in the hippocampal formation as a function of the clinical progression of Alzheimer disease. Arch Neurol 58:487-492
24. Pasinetti GM, Aisen PS (1998) Cyclooxygenase-2 expression is increased in frontal cortex of Alzheimer's disease brain. Neuroscience 87:319-324
25. Andreasson KI, Savonenko A, Vidensky S, et al. (2001) Age-dependent cognitive deficits and neuronal apoptosis in cyclooxygenase-2 transgenic mice. J Neurosci 21:8198-8209
26. Kelley KA, Ho L, Winger D, et al. (1999) Potentiation of excitotoxicity in transgenic mice overexpressing neuronal cyclooxygenase-2. Am J Pathol 155:995-1004
27. Landreth GE, Heneka MT (2001) Anti-inflammatory actions of peroxisome proliferator-activated receptor gamma agonists in Alzheimer's disease. Neurobiol Aging 22:937-944
28. Lim GP, Yang F, Chu T, et al. (2001) Ibuprofen effects on Alzheimer pathology and open field activity in APPsw transgenic mice. Neurobiol Aging 22:983-991
29. Weggen S, Eriksen JL, Das P, et al. (2001) A subset of NSAIDs lower amyloidogenic Abeta42 independently of cyclooxygenase activity. Nature 414:212-216
30. th International Congress on Alzheimer's Disease, Stockholm. Neurobiol Aging 23:S286
31. In 't Veld BA, Ruitenberg A, Hofman A, et al. (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 345:1515-1521
32. Breitner JC, Zandi PP (2001) Do non-steroidal antiinflammatory drugs reduce the risk of Alzheimer's disease? N Engl J Med 345:1567-1568
33. Arends YM, Duyckaerts C, Rozemuller JM, Eikelenboom P, Hauw JJ (2000) Microglia, amyloid and dementia in Alzheimer disease. A correlative study. Neurobiol Aging 21:39-47
34. Cagnin A, Brooks DJ, Kennedy AM, et al. (2001) In-vivo measurement of activated microglia in dementia. Lancet 358:461-467